Heiko Julius
Papers
1
Total Citations
41
H-Index
1
About
Heiko Julius is a distinguished researcher in the fields of epigenetics and high-throughput screening, with a primary focus on histone deacetylase (HDAC) biology and assay development. His most notable contribution is the development of a homogeneous cellular HDAC assay, detailed in his 2007 paper, which has garnered 41 citations. This work revolutionized compound profiling and robotic screening by enabling efficient, cell-based evaluation of HDAC inhibitors—key tools in cancer and neurological disease research. Julius’s assay design streamlined drug discovery, allowing researchers to assess compound efficacy and selectivity in a physiologically relevant context, bridging the gap between biochemical and cellular assays. His achievements include advancing the methodology for epigenetic drug screening, which has been widely adopted in both academic and pharmaceutical settings. By providing a robust platform for identifying novel HDAC modulators, Julius has significantly impacted the development of targeted therapies. His work remains a cornerstone for scientists exploring epigenetic mechanisms and therapeutic interventions, underscoring his role as a pioneer in cellular assay technology for drug discovery.
Research Focus
Key Achievements
Top Papers
- 1